Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07459556

A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

Sponsor: Chengdu Kangnuoxing Biopharma,Inc.

View on ClinicalTrials.gov

Summary

This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.

Official title: A Prospective Study of Stapokibart Injection in Patients With SAR

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

400

Start Date

2026-03

Completion Date

2028-02

Last Updated

2026-03-09

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

Stapokibart

subcutaneous injection

Locations (1)

Beijing Tongren Hospital, CMU

Beijing, China